An audit of cervical cytology in HIV-positive women.
OBJECTIVE
To investigate whether a cohort of human immunodeficiency virus-positive (HIV+) women were having annual cervical cytology as recommended by the English National Health Service cervical screening programme (NHSCSP) guidelines.


METHODS
An audit of cervical cytology in an HIV+ cohort of 187 women by obtaining their last cervical cytology result and recall from local cytology services.


RESULTS
Of the 187 women in the audit, two were ineligible, leaving 185 women, 167 (90.3%) of whom were aged 25-64 years and eligible for screening. Of the 185 women, 126 (68.1%) had a cytology history, 50 (27%) had never had cervical cytology and nine (4.9%) had inadequate details to ascertain whether or not they had a cytology history. Of the 126 with a cytology record, 34 (27%) had a current cytological abnormality, which was low grade in 25 (19.8%) and high grade in nine (7.1%). Among women aged 25-64 years attending the clinic, these percentages were significantly higher than expected for England as a whole (P < 0.001). Of 126 women with a cytology record, 29 (23%) were overdue for their recall date and of these the previous test was abnormal in 14 (48.3%). Cytology tests were taken within the community setting in 61 (48.4%), whereas 65 (51.6%) were seen either at an HIV sexual health clinic or were under colposcopy follow-up. Of 91 women with negative cytology only 50 (54.9%) were recommended for repeat in 12 months.


CONCLUSIONS
This audit demonstrates a high rate of cytological abnormalities among HIV+ women compared with the screening population at large. Implementation of NHSCSP guidelines has been difficult and requires improved care pathways between HIV clinics, primary care and laboratories.
Hotonu
O E O
OE
Department of Infection & Tropical Medicine, Newcastle General Hospital, Newcastle Upon Tyne, UK. oluseyi.hotonu@newcastle-pct.nhs.uk
Hussey
J
J
Basta
M S T
MS
Wadehra
V
V
Cross
P
P
Schmid
M L
ML
D000328:Adult; D002584:Cervix Uteri / Q000473:pathology*; D015331:Cohort Studies; D003127:Colposcopy; D015897:Comorbidity; D003955:Diagnostic Tests, Routine; D005260:Female; D019983:Guideline Adherence; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008485:Medical Audit; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D014626:Vaginal Smears / Q000706:statistics & numerical data; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis*